Compare Enzyme (MLN) vs Celestia (TIA) Price & Performance

Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.

Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.

Celestia (TIA) trades at Rp5,591 with a market cap of Rp5.13T, showing a bearish technical signal as moving averages indicate strong selling pressure. The price is testing support near Rp5,442, with neutral oscillators suggesting potential consolidation. No major protocol updates or ecosystem news have been reported recently, keeping fundamental developments quiet.

Overall outlook remains cautious due to bearish technicals and lack of positive catalysts. Key opportunities include potential rebounds from oversold RSI levels, while major risks involve continued selling pressure and low market sentiment. Investors should monitor support breaks for downside risks.